Translocator protein TSPO 18 kDa and its ligands: a promising approach to the creation of new neuropsychotropic drug

Resume. It is 41 years in 2018 since Braestrup and Squires opened translocator protein 18 kDa TSPO, known until 2006 as the peripheral benzodiazepine receptor (PBR). The functions of this receptor, which is one of the most important component of the outer mitochondrial membrane, have been studied in...

Celý popis

Podrobná bibliografie

Hlavní autoři:	G. V. Mokrov, O. A. Deeva, M. A. Yarkova, T. A. Gudasheva, S. B. Seredenin
Médium:	Artigo
Jazyk:	Russo
Vydáno:	LLC “Publisher OKI” 2018-11-01
Edice:	Фармакокинетика и Фармакодинамика
Témata:	транслокаторный белок tspo 18 кда лиганды tspo нейропсихотропная активность дизайн новых лекарственных средств нейростероиды translocator protein tspo 18 kda tspo ligands neuropsychotropic activity design of new drugs neurosteroids
On-line přístup:	https://www.pharmacokinetica.ru/jour/article/view/72
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!